Among genes uniquely downregulated by CBPD-409, we identified NKX3-1, CITED2 and CCND1, which are known for their critical roles in prostate cancer progression45–47 (Fig. 4f and Extended Data Fig. 7e). This evidence concerns the gene NKX3-1 and prostate carcinoma.